Analyst Ratings for Lakefront Biotherapeutics (LKFT)
LKFT Rating Summary
LKFT Price Target Summary
- Highest: $26.00 (Morgan Stanley)
- Lowest: $26.00 (Morgan Stanley)
- Average: $26.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$26.00 (-8.9%)
* Over Last 12-Mos
Rating Score: 5 / 10
Avg. $ Target:
$26.00 (-8.9%)
* Over Last 12-Mos
Rating Score: 5 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/21/2026 | TD Cowen | Phil Nadeau | New Coverage | Buy (N/A) |
N/A (N/A) |
28.27 (28.55) |
0.99% | Details |
| 7/10/2026 | Morgan Stanley » Updated 8/11/2026 |
Judah Frommer | New Coverage | Equalweight (N/A) |
26.00 (30.00) |
30.81 (28.55) |
-7.34% | Details |
